EU drug agency discounts any link between vaccine and clots
LONDON (AP) — The European Union's drug regulatory agency says experts have concluded that the AstraZeneca vaccine is not linked to an overall increase in the risk of blood clots and that the benefits of use outweigh the risks.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
